ARYx Therapeutics   Report issue

For profit Phase 2 Phase 3
Founded: Fremont CA United States (1997)
Status: Defunct (2011)

Organization Overview

First Clinical Trial
2005
NCT01094821
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

tecarfarin (2 trials)

warfarin (coumadin) (1 trial)

Drugs in Phase 2 Trials (2)

budiodarone (1 trial)

naronapride (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 3)

Atrial Flutter (Phase 3)

Cardiomyopathies (Phase 3)

Infarction (Phase 3)

Myocardial Infarction (Phase 3)

Syndrome (Phase 2)

Thromboembolism (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 5
  • # of Trial APIs: 4